Treatment with thi, an inhibitor of sphingosine-1-phosphate lyase (sgpl1), modulates glycosphingolipid metabolism and results therapeutically effective in a mouse model of huntington's disease
I: Experimental therapeutics – preclinical（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要